title: Experimental gliosarcoma induces chemokine receptor expression in rat brain.
abstract: Macrophage/microglial infiltration is a characteristic feature of brain tumors. The functional role(s) of these cells is complex and could include both trophic and suppressive effects on tumors. Information has recently emerged about the molecular signals that regulate the accumulation and function of monocytes in pathological disorders. Recent data indicate that the chemokine, monocyte chemoattractant protein-1 (MCP-1), a potent monocyte activating and chemotactic factor, is a primary regulator of the macrophage response in brain tumors. We hypothesized that if MCP-1 regulates macrophage/microglial infiltration, then expression of the specific MCP-1 receptor, CCR2, will be induced in peritumoral tissue and/or within brain tumors. Identification of a specific receptor that is preferentially expressed in brain tumors could be important both in terms of tumor biology and as a potential therapeutic target. We used an established experimental gliosarcoma model, induced by intracranial transplantation of cultured 9L cells into adult rat brain, to test this hypothesis. RT-PCR analysis showed high levels of both MCP-1 and CCR2 mRNA and Western blot analysis demonstrated increased CCR2 protein in tumor extracts. Immunocytochemistry showed CCR2 immunoreactive microglia in peritumoral tissue and, unexpectedly, that intrinsic tumor cells, rather than monocytes, were the predominant source of CCR2. These results demonstrate that CCR2 expression is markedly upregulated in this brain tumor model.
authors.affiliation: Neuroscience Program, University of Michigan, Ann Arbor, Michigan, 48109-0646, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Galasso
authors.forename: L D
authors.initials: LD
authors.lastname: Stegman
authors.forename: M
authors.initials: M
authors.lastname: Blaivas
authors.forename: J K
authors.initials: JK
authors.lastname: Harrison
authors.forename: B D
authors.initials: BD
authors.lastname: Ross
authors.forename: F S
authors.initials: FS
authors.lastname: Silverstein
mesh_terms: D000818:Animals; D001324:Autoantigens / Q000032:analysis / Q000235:genetics*; D015153:Blotting, Western; D001923:Brain Chemistry / Q000235:genetics / Q000276:immunology; D001932:Brain Neoplasms / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology; D018932:Chemokine CCL2; D017931:DNA Primers; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D018316:Gliosarcoma / Q000175:diagnosis / Q000276:immunology* / Q000503:physiopathology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008264:Macrophages / Q000276:immunology; D008279:Magnetic Resonance Imaging; D008297:Male; D017628:Microglia / Q000502:physiology; D009368:Neoplasm Transplantation; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D011916:Rats, Inbred F344; D054390:Receptors, CCR2; D019707:Receptors, Chemokine; D018121:Receptors, Cytokine / Q000032:analysis / Q000235:genetics*
chemical_list: D001324:Autoantigens; C491766:Ccl2 protein, rat; C515336:Ccr2 protein, rat; D018932:Chemokine CCL2; D017931:DNA Primers; D008070:Lipopolysaccharides; D012333:RNA, Messenger; D054390:Receptors, CCR2; D019707:Receptors, Chemokine; D018121:Receptors, Cytokine